Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Children with systemic lupus erythematosus have different skin symptoms than adults.

A 16-year-old girl with lupus symptoms improved with treatment despite negative ANA tests.

New treatments and understanding of skin lupus are emerging in 2024.

The woman was diagnosed with lichen sclerosus, a rare skin condition, after initial misdiagnosis and ineffective treatments.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

Lupus Panniculitis can be an early sign of Systemic Lupus Erythematosus.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

SLE can occur in young males and cause knee pain.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Dermoscopy helped diagnose discoid lupus erythematosus in two patients without needing skin biopsies.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Researchers found a new mutation in the HR gene causing hair loss and skin bumps in a Pakistani family.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.